| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2972974 | The Journal of Heart and Lung Transplantation | 2006 | 5 Pages |
Abstract
Rabbit anti-thymocyte globulin is more effective than basiliximab for prevention of rejection episodes after heart transplantation. Both induction agents provide similar safety profile.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Flavia MD, Shelley MD, Vivek MD, PhD, Heather MD, MsH, Diego H. MD, MSc,